Location History:
- Ventura, CA (US) (2012 - 2013)
- San Diego, CA (US) (2008 - 2015)
- Camarillo, CA (US) (2014 - 2016)
Company Filing History:
16 out of 164 
7 out of 38 
1 out of 832,912 Years Active: 2008-2016
Title: Innovator Spotlight: Christine Marie Mack
Introduction
Christine Marie Mack is a distinguished inventor based in San Diego, California. With an impressive portfolio of 17 patents, she has made significant contributions to the field of metabolic disease treatments and innovations. Her work has paved the way for advancements in understanding and managing conditions such as diabetes and hypertension.
Latest Patents
Among her notable inventions are two recent patents that showcase her innovative approach to addressing metabolic disorders. The first patent, titled "Hybrid polypeptides with selectable properties," focuses on novel hybrid polypeptides designed to help treat and prevent metabolic diseases by regulating plasma glucose levels, insulin levels, and insulin secretion. This invention targets a range of conditions, including hypertension, dyslipidemia, cardiovascular diseases, eating disorders, insulin resistance, obesity, and diabetes mellitus types 1, 2, and gestational diabetes.
The second patent, "GIP analog and hybrid polypeptides with selectable properties," details GIP analogs and hybrid polypeptides that serve similar purposes. This invention is aimed at enhancing treatments for metabolic diseases, providing benefits such as positive inotropic effects, reducing catabolic effects, and slowing gastric emptying, thus tackling the same array of health issues.
Career Highlights
Christine has lent her expertise to prominent pharmaceutical companies, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. Her experience within these organizations has not only honed her skills as an inventor but also driven her passion for innovation in the healthcare sector.
Collaborations
Throughout her career, Christine has collaborated with accomplished professionals, including David Geoffrey Parkes and Michael R. Hanley. These partnerships have enriched her work, allowing for shared insights and advancements in the metabolism research field.
Conclusion
Christine Marie Mack exemplifies the role of a visionary inventor, pushing the boundaries of scientific research to improve lives affected by metabolic diseases. With her continued efforts and innovations, she is sure to leave a lasting impact on the medical community and beyond.